Supernus Pharmaceuticals Inc’s recently made public that its Sr. VP of IP, CSO Bhatt Padmanabh P. unloaded Company’s shares for reported $0.79 million on Dec 03 ’24. In the deal valued at $36.68 per share,21,495 shares were sold. As a result of this transaction, Bhatt Padmanabh P. now holds 9,679 shares worth roughly $0.36 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, PADMANABH P BHATT bought 21,495 shares, generating $801,978 in total proceeds.
Before that, NEWHALL CHARLES W III sold 10,700 shares. Supernus Pharmaceuticals Inc shares valued at $387,768 were divested by the Director at a price of $36.24 per share. As a result of the transaction, NEWHALL CHARLES W III now holds 130,275 shares, worth roughly $4.84 million.
Piper Sandler downgraded its Supernus Pharmaceuticals Inc [SUPN] rating to a Neutral from a an Overweight in a research note published on September 11, 2024; the price target was decreased to $36 from $41. Jefferies revised its rating on April 13, 2021. It rated SUPN as “a Buy” which previously was an “a Hold”.
Price Performance Review of SUPN
On Friday, Supernus Pharmaceuticals Inc [NASDAQ:SUPN] saw its stock jump 2.48% to $37.18. Over the last five days, the stock has gained 3.94%. Supernus Pharmaceuticals Inc shares have risen nearly 28.47% since the year began. Nevertheless, the stocks have risen 25.27% over the past one year. While a 52-week high of $39.37 was reached on 11/05/24, a 52-week low of $25.53 was recorded on 06/14/24. SMA at 50 days reached $35.80, while 200 days put it at $31.89.
Levels Of Support And Resistance For SUPN Stock
The 24-hour chart illustrates a support level at 36.14, which if violated will result in even more drops to 35.10. On the upside, there is a resistance level at 37.78. A further resistance level may holdings at 38.38. The Relative Strength Index (RSI) on the 14-day chart is 60.05, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.17, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 13.58%. Stochastics %K at 60.91% indicates the stock is a holding.
How much short interest is there in Supernus Pharmaceuticals Inc?
A steep rise in short interest was recorded in Supernus Pharmaceuticals Inc stocks on 2024-12-13, growing by 0.11 million shares to a total of 6.64 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 6.52 million shares. There was a rise of 1.72%, which implies that there is a positive sentiment for the stock.
